2 months ago
2
Granules Life Sciences (GLS) manufacturing installation successful Shamirpet, adjacent Hyderabad, has been classified arsenic voluntary enactment indicated (VAI) by the U.S. Food and Drug Administration (U.S. FDA) consequent to an inspection successful December 2025.
The constitution inspection study (EIR) was issued pursuing a existent bully manufacturing signifier (cGMP) and pre-approval inspection (PAI) of the oral coagulated dosage manufacturing operations betwixt December 15 and 19. The inspection is present closed and nary regulatory enactment has been recommended, genitor institution Granules India said connected Tuesday (March 31, 2026).
Granules gets Board motion to rise ₹1,762.5 crore
The improvement strengthens Granules India’s finished dosage manufacturing capabilities by enabling multi-site manufacturing for the approved products, the institution said.
Five observations issued
The U.S. FDA had issued 5 observations connected completion of the inspection successful December. The observations were related to procedural requirements. None of the observations are associated with information integrity oregon merchandise safety, the institution had past said. Granules Life Sciences is into manufacturing of pharmaceutical formulation intermediates (PFIs) and finished dosages.
“While receiving the [VAI] classification is simply a measurement successful the close direction, we recognise prime is not a one-time milestone but an ongoing commitment. It volition proceed to stay a halfway pillar of utmost value crossed each Granules sites,” CMD Krishna Prasad Chigurupati said.
VAI is 1 of the 3 classifications the U.S. FDA issues, successful its EIR. VAI means objectionable conditions oregon practices were found, but it is not prepared to instrumentality oregon urge immoderate administrative oregon regulatory action. No enactment indicated (NAI) is different classification, which means nary objectionable conditions oregon practices were recovered during the inspection. The 3rd class of classification is authoritative enactment indicated (OAI) that means regulatory and/or administrative actions are recommended.
